Posted by Michael Wonder on 25 Nov 2021
Comirnaty COVID-19 vaccine: EMA recommends approval for children aged 5 to 11
25 November 2021 - EMA’s CHMP has recommended granting an extension of indication for the COVID-19 vaccine Comirnaty to include use in children aged 5 to 11.
The vaccine, developed by BioNTech and Pfizer, is already approved for use in adults and children aged 12 and above.
